Alkermes
ALKS | NASDAQ
$44.18
+$0.79 (+1.82%)
At close: Sep 21, 2026, 4:00 PM ET
$44.60
+$0.42 (+0.95%)
Pre-market:
Sep 22, 2026, 4:46 AM ET
90-Day Net Volume
-$4.24M
90-Day Activity
0 Buys / 10 Sales
All-Time Net Volume
-$48.91M
Total Filings
1,141
Insider Trading Activity
| Name | Transaction Date | Transaction Type | Shares | Price | Value |
|---|---|---|---|---|---|
Gaffin David Joseph EVP, CLO, Alkermes, Inc. | Sep 3, 2026 | S-Sale Ordinary Shares | 2,034 | 48.01 | $97,652 |
Hopkinson Craig C. EVP R&D, Chief Medical Officer | Sep 1, 2026 | S-Sale Ordinary Shares | 9,000 | 46.99 | $422,874 |
Nichols Christian Todd SVP, Chief Commercial Officer | Aug 17, 2026 | S-Sale Ordinary Shares | 6,912 | 49.19 | $339,967 |
Pro Membership
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
Unlimited access
Unlimited access to all data and tools, giving you the edge over everyone else in the market.
Proprietary Stock Rating Score
Evaluate stocks with our proprietary rating score based on fundamentals, economic moat, and sentiment.
Top Wall Street Analyst Ratings
Follow ratings from the best analysts on Wall Street to stay ahead of market moves.
Up to 30 years financial history
We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.
Add to Watchlist
Select watchlists to add or remove ALKS